Introduction and Context
The American Diabetes Association (ADA) publishes annual “Standards of Medical Care in Diabetes” to consolidate the latest evidence and provide actionable clinical recommendations. The 2024 Standards (Diabetes Care. 2024;47[S1]) arrive amid a rapid expansion of diabetes and obesity pharmacotherapy, growing evidence for cardiorenal protection from drug classes originally developed for glucose lowering, and wider adoption of diabetes technologies. These shifts created an urgent need to integrate new trial data and real-world considerations into clinical pathways.
Why this update matters now